摘要
由21号染色体三体引起的唐氏综合征(DS),以智力障碍(ID)和阿尔茨海默病(AD)的早期发病的病理改变为特点,包括海马胆碱能投射系统的退化。本篇我们确定年龄和母体的胆碱补充(MCS)对Ts65Dn小鼠海马胆碱能缺陷的影响,与6-8月龄和14-18月龄的2N小鼠作比较。Ts65Dn小鼠和二体(2N)小鼠在6-8月龄、14-18月龄被处死用于老化的研究, 从生产后的Ts65Dn 小鼠分出的Ts65Dn和2N的小鼠维持补充胆碱或胆碱-对照(从怀孕到断奶期)饮食,在14-18月龄进行检测研究MCS。在后者的研究里,用径向臂水迷宫实验(RAWM)做行为测试,并检测海马组织的胆碱乙酰转移酶(ChAT)的免疫反应性。在单独的群组里评价海马胆碱乙酰转移酶(ChAT)的免疫活性。Ts65Dn小鼠海马和齿状回胆碱乙酰转移酶(ChAT)阳性神经纤维分布显著高于2N的小鼠,不受年龄或孕期饮食的限制。同样地, 与2N的小鼠相比,Ts65Dn小鼠的胆碱乙酰转移酶(ChAT)活性显著升高,不受年龄或孕期饮食的限制。随着年龄的增长,2N小鼠的海马胆碱能神经分布显着增加,而不是Ts65Dn小鼠。胆碱乙酰转移酶(ChAT)强度与未补充胆碱的2N和Ts65Dn小鼠的空间记忆能力呈负相关,但与母体胆碱补充的2N小鼠正相关。因母体胆碱的补充而增加的神经分布显示了海马功能的改善,,可以利用此转化途径用于将来对人类的唐氏综合症的治疗。
关键词: Aging
Current Alzheimer Research
Title:Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome
Volume: 13 Issue: 1
Author(s): Christy M. Kelley, Jessica A. Ash, Brian E. Powers, Ramon Velazquez, Melissa J. Alldred, Milos D. Ikonomovic and Stephen D. Ginsberg, Barbara J. Strupp and Elliott J. Mufson
Affiliation:
关键词: Aging
摘要: Down syndrome (DS), caused by trisomy of chromosome 21, is marked by intellectual disability (ID) and early onset of Alzheimer’s disease (AD) neuropathology including hippocampal cholinergic projection system degeneration. Here we determined the effects of age and maternal choline supplementation (MCS) on hippocampal cholinergic deficits in Ts65Dn mice compared to 2N mice sacrificed at 6-8 and 14-18 months of age. Ts65Dn mice and disomic (2N) littermates sacrificed at ages 6-8 and 14-18 mos were used for an aging study and Ts65Dn and 2N mice derived from Ts65Dn dams were maintained on either a choline-supplemented or a choline-controlled diet (conception to weaning) and examined at 14-18 mos for MCS studies. In the latter, mice were behaviorally tested on the radial arm Morris water maze (RAWM) and hippocampal tissue was examined for intensity of choline acetyltransferase (ChAT) immunoreactivity. Hippocampal ChAT activity was evaluated in a separate cohort. ChAT-positive fiber innervation was significantly higher in the hippocampus and dentate gyrus in Ts65Dn mice compared with 2N mice, independent of age or maternal diet. Similarly, hippocampal ChAT activity was significantly elevated in Ts65Dn mice compared to 2N mice, independent of maternal diet. A significant increase with age was seen in hippocampal cholinergic innervation of 2N mice, but not Ts65Dn mice. Degree of ChAT intensity correlated negatively with spatial memory ability in unsupplemented 2N and Ts65Dn mice, but positively in MCS 2N mice. The increased innervation produced by MCS appears to improve hippocampal function, making this a therapy that may be exploited for future translational approaches in human DS.
Export Options
About this article
Cite this article as:
Christy M. Kelley, Jessica A. Ash, Brian E. Powers, Ramon Velazquez, Melissa J. Alldred, Milos D. Ikonomovic and Stephen D. Ginsberg, Barbara J. Strupp and Elliott J. Mufson , Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome, Current Alzheimer Research 2016; 13 (1) . https://dx.doi.org/10.2174/1567205012666150921100515
DOI https://dx.doi.org/10.2174/1567205012666150921100515 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Focal Adhesion Kinase as a Cancer Therapy Target
Anti-Cancer Agents in Medicinal Chemistry Implication of Green Tea as a Possible Therapeutic Approach for Parkinson Disease
CNS & Neurological Disorders - Drug Targets Structure and Mechanism of Action of Tau Aggregation Inhibitors
Current Alzheimer Research P2X Receptors and Inflammation
Current Medicinal Chemistry The High Throughput Biomedicine Unit at the Institute for Molecular Medicine Finland: High Throughput Screening Meets Precision Medicine
Combinatorial Chemistry & High Throughput Screening Survival Signaling Pathways Activated by NMDA Receptors
Current Topics in Medicinal Chemistry Withdrawal Notice: Drug Repurposing for Prospective Anti-Cancer Agents Along with the Clinical Status of the Repurposed Drug
Anti-Cancer Agents in Medicinal Chemistry Nitric Oxide Synthases and Their Natural Inhibitors
Current Enzyme Inhibition Inhibition of Autophagy Strengthens Celastrol-Induced Apoptosis in Human Pancreatic Cancer In Vitro and In Vivo Models
Current Molecular Medicine Neuroprotective Effect of β-secretase Inhibitory Peptide from Pacific Hake (Merluccius productus) Fish Protein Hydrolysate
Current Alzheimer Research Copper Compounds in Anticancer Strategies
Current Medicinal Chemistry Design and Microwave-Assisted Synthesis of Aza-Resveratrol Analogs with Potent Cholinesterase Inhibition
CNS & Neurological Disorders - Drug Targets Atypical PKCι as Target for Glioblastoma Therapy
Current Cancer Drug Targets Modulation of Rack-1/PKCβII Signalling By Soluble AβPPα in SH-SY5Y Cells
Current Alzheimer Research Innovative Drug Delivery Systems for the Administration of Natural Compounds
Current Bioactive Compounds Hsp20 Protects Neuroblastoma Cells from Ischemia/Reperfusion Injury by Inhibition of Apoptosis via a Mechanism that Involves the Mitochondrial Pathways
Current Neurovascular Research Treating Schizophrenia: Novel Targets for the Cholinergic System
CNS & Neurological Disorders - Drug Targets Diagnostic and Prognostic Markers in Differentiated Thyroid Cancer
Current Genomics Targeting Vesicle Trafficking: An Important Approach to Cancer Chemotherapy
Recent Patents on Anti-Cancer Drug Discovery How Would Composite Traditional Chinese Medicine Protect the Brain – An Example of the Composite Formula “Pien Tze Huang”
Current Medicinal Chemistry